← Back to Search

Questionnaires for Endometriosis (20900 Trial)

N/A
Waitlist Available
Led By Patrick Yeung, MD
Research Sponsored by St. Louis University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female patients 13-55 years of age
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every 12 months
Awards & highlights

20900 Trial Summary

This trial is collecting data on women with endometriosis or suspected endometriosis to help develop better treatment guidelines and to study the disease further.

Who is the study for?
This trial is for women aged 13-55 seeking treatment at the Center for Endometriosis, who may have endometriosis or related symptoms like pain and infertility. It's not open to those who've had both ovaries and fallopian tubes removed, are post-menopausal naturally, or have mental/systemic illnesses affecting pain assessment.Check my eligibility
What is being tested?
The study involves collecting data through questionnaires from participants as part of their regular medical care. This information will help develop surgical guidelines for endometriosis and aid in future tests for diagnosis and staging of the condition.See study design
What are the potential side effects?
Since this trial uses questionnaires rather than medical treatments, there are no direct physical side effects associated with participating. However, discussing sensitive health issues could potentially cause emotional discomfort.

20900 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a female aged between 13 and 55.

20900 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and every 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality of life, pain and fertility

Side effects data

From 2020 Phase 2 trial • 19 Patients • NCT03006848
17%
Musculoskeletal and connective tissue disorders
11%
Injury, poisoning and procedural complications
6%
Gastrointestinal disorders
6%
General disorders and administration site conditions
6%
Metabolism and nutrition disorders
6%
Nervous system disorders
6%
Immune system disorders
6%
Investigations
6%
Cardiac disorders
6%
Endocrine disorders
6%
Blood and lymphatic system disorders
6%
Neoplasms benign, malignant and unspecified
6%
Respiratory, thoracic and mediastinal disorders
6%
Infections and infestations
6%
Renal and urinary disorders
6%
Skin and subcutaneous tissue disorders
100%
80%
60%
40%
20%
0%
Study treatment Arm
Avelumab

20900 Trial Design

1Treatment groups
Experimental Treatment
Group I: EndometriosisExperimental Treatment1 Intervention
Patients whom pathology results post surgery document endometriosis

Find a Location

Who is running the clinical trial?

St. Louis UniversityLead Sponsor
194 Previous Clinical Trials
41,405 Total Patients Enrolled
2 Trials studying Endometriosis
125 Patients Enrolled for Endometriosis
Patrick Yeung, MDPrincipal InvestigatorSt. Louis University
1 Previous Clinical Trials
46 Total Patients Enrolled

Media Library

Endometriosis Clinical Trial Eligibility Overview. Trial Name: NCT03002870 — N/A
Endometriosis Research Study Groups: Endometriosis
Endometriosis Clinical Trial 2023: Endometriosis Highlights & Side Effects. Trial Name: NCT03002870 — N/A
Endometriosis 2023 Treatment Timeline for Medical Study. Trial Name: NCT03002870 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the age restriction for this medical research include adults over 35?

"The current trial only accepts patients aged between 13 and 55. However, there are other clinical studies available for those below the age of majority or above retirement age with 4 trials targeting minors and 13 experiments focused on seniors."

Answered by AI

Which individuals are eligible to enroll in this research program?

"Eligibility criteria for this clinical trial includes being between the ages of 13 and 55, as well as having a diagnosis of endometrioma. Approximately 2000 people are expected to enroll in total."

Answered by AI

Are there any slots available for enrollment in this clinical trial currently?

"The record on clinicaltrials.gov reveals that this trial is no longer accepting patients, having first been posted on September 1st 2016 and last updated nine days ago. However, there are 87 other trials currently in the recruitment stage for potential participants."

Answered by AI

Who else is applying?

What state do they live in?
Maryland
What portion of applicants met pre-screening criteria?
Did not meet criteria
~315 spots leftby Sep 2025